References
- Brydges S, Kastner DL. The systemic autoinflammatory diseases: inborn errors of the innate immune system. Curr. Top. Microbiol. Immunol.305, 127–160 (2006).
- McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLOS Med.3(8), e297 (2007).
- Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science320(5876), 674–677 (2008).
- Gattorno M, Piccini A, Lasigliè D et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum.25(58), 1505–1515 (2008).
- Murdoch S, Djuric U, Mazhar B et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat. Genet.38, 300–302 (2006).
- Goldbach-Mansky R, Dailey NJ, Canna SW et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition. N. Engl. J. Med.355(6), 581–592 (2006).
- Jéru I, Duquesnoy P, Fernandes-Alnemri T et al. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc. Natl Acad. Sci. USA105, 1614–1619 (2008).
- Kalyoncu M, Acar BC, Cakar N et al. Are carriers for MEFV mutations ‘healthy’? Clin. Exp. Rheumatol.24(5 Suppl. 42), S120–S122 (2006).
- La Regina M, Nucera G, Diaco M et al. Familial Mediterranean fever is no longer a rare disease in Italy. Eur. J. Hum. Genet.11, 50–56 (2003).
- Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin. Exp. Rheumatol.24(5 Suppl. 42), S99–S103 (2006).
- Mandey SH, Kuijk LM, Frenkel J, Waterham HR. A role for geranylgeranylation in interleukin-1β secretion. Arthritis Rheum.54, 3690–3695 (2006).
- Ammouri W, Cuisset L, Rouaghe S et al. Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford)46, 1597–1600 (2007).
- Lobito AA, Kimberley FC, Muppidi JR et al. Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood108(4), 1320–1327 (2006).
- Todd I, Radford PM, Daffa N et al. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients’ leukocytes. Arthritis Rheum.56, 2765–2773 (2007).
- Nedjai B, Hitman GA, Yousaf N et al. Abnormal TNFR1 cell surface expression and NF-κB activation in TNFR1-associated periodic periodic syndrome (TRAPS). Arthritis Rheum.58, 273–283 (2008).
- Churchman SM, Church LD, Savic S et al. A novel TNFRSF1A splice mutation associated with increased NF-κB transcription factor activation in patients with TNF-receptor associated periodic syndrome (TRAPS). Ann. Rheum. Dis. DOI: 10.1136/ard.2007.078667 (2007) (Epub ahead of print).
- Ferguson PJ, Chen S, Tayeh MK et al. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J. Med. Genet.42, 551–557 (2005).
- Milhavet F, Cuisset L, Hoffman HM et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum. Mutat.29(6), 803–808 (2008).